NCT01973335
Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure
See it on ClinicalTrials.gov ↗34 people
35.3%
64.7%
12 womenmiddle line = equal numbers22 men
- Phase
- PHASE4
- Paid for by
- Hasselt University
- Finished
- 2017-10
- Health conditions
- Heart Failure
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 80 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 100% · American Indian / Alaska Native 0% · Asian 0% · Native Hawaiian / Pacific Islander 0% · Black / African American 0% · More than one race 0% · Not reported 0%
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“A baseline estimated glomerular filtration rate \<15 mL/min/1.73m² according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula at the moment of inclusion”
Study titles and rules are shown in their original English.